Company profile: NX Development
1.1 - Company Overview
Company description
- Provider of real-time intra-operative imaging agents. Offers Gleolan, an optical imaging agent used during brain tumor resection to visualize malignant tissue, and Phase 3 studies assessing Gleolan for detecting and visualizing meningiomas (MEN-301) and investigating its real-time detection and visualization of ovarian cancer during debulking surgery (OVA-302).
Products and services
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma (MEN-301): A Phase 3 clinical study evaluating Gleolan’s safety and effectiveness in detecting and visualizing meningiomas during surgery in newly diagnosed or recurrent cases
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302): A Phase 3 trial investigating Gleolan’s real-time detection and visualization of ovarian cancer during debulking surgery in newly diagnosed or recurrent disease
- Gleolan: An optical imaging agent used during brain tumor resection to help visualize malignant tissue during surgery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NX Development
Centerline Biomedical
HQ: United States
Website
- Description: Provider of the IOPS (Intra-Operative Positioning System), a 3D surgical navigation and visualization technology that improves endovascular procedure outcomes and reduces radiation exposure; used in FDA-cleared Endovascular Aortic Repair, Peripheral Artery Disease procedures, and structural heart interventions. Cleveland Clinic spin-off.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centerline Biomedical company profile →
Momentis Surgical
HQ: Israel
Website
- Description: Provider of robotic surgical solutions enabling simple, minimally invasive and cost-effective procedures, including the Anovo Surgical System for transvaginal gynecological surgery with humanoid-shaped arms that mimic a surgeon’s precise movements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Momentis Surgical company profile →
Olive Medical
HQ: United States
Website
- Description: Provider of affordable HD MIS imaging equipment for the OR, including the TCK1 HD Camera Head and OVB1 HD Camera Control Unit delivering 'True HD' MIS visualization with intuitive controls and lightweight ergonomics. Based in Salt Lake City, UT.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olive Medical company profile →
ClearFlow
HQ: United States
Website
- Description: Provider of medical devices and education addressing obstructed catheters and chest tube management, including PleuraFlow ACT to proactively remove clots from chest tubes to prevent occlusion and ensure evacuation of blood and fluid post-surgery, and ClearFix Rigid Sternal Fixation for stabilizing anterior chest wall fractures, including sternal fixation after sternotomy and reconstructive procedures; also offers clinical webinars and training to improve cardiothoracic outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClearFlow company profile →
Alesi Surgical
HQ: United Kingdom
Website
- Description: Provider of surgical smoke management and visibility solutions that improve the safety, efficacy and outcomes of laparoscopic procedures, including Ultravision, an electrostatic precipitation system that minimizes surgical smoke without gas exchange; Ionwand, a device that creates negatively charged ions to clear smoke; and Ultravision2, a next‑generation generator optimizing Ultravision energy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alesi Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NX Development
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NX Development
2.2 - Growth funds investing in similar companies to NX Development
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NX Development
4.2 - Public trading comparable groups for NX Development
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →